Dabigatran Etexilate 59651-0973
Product NDC
59651-0973- Manufacturer
- Aurobindo Pharma Limited
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 14, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA208039
Need to source Dabigatran Etexilate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dabigatran Etexilate Mesylate | 75 mg/1 |
Drug Class
Direct Thrombin Inhibitor [EPC]Thrombin Inhibitors [MoA]
Packaging Options(2)
60 CAPSULE in 1 BOTTLE (59651-973-60)
10 BLISTER PACK in 1 CARTON (59651-973-61) / 6 CAPSULE in 1 BLISTER PACK